Pfizer's $2bn+ obesity bet, and other weight-loss news Pfizer licenses another GLP-1 agonist from YaoPharma, plus clinical updates from Zealand, Structure, Ascletis, Wave, and Boehringer Ingelheim.

#Pfizer #obesity #weightloss #FosunPharma #YaoPharma #GLP1agonist #oralGIPanalogue #Metsera #EliLilly #NovoNordisk #Wegovy #ZealandPharma #metabolicdiseases #Roche #BoehringerIngelheim #GLP1glucagonagonist #StructureTherapeutics #AscletisPharma #WaveLifeSciences #Gubra
zurl.co/AwsrK

A university technology transfer success story www.ipgroupplc.com/news-and-eve... #Metsera #Zihipp

Pfizer Clinches $10 Billion Deal to Acquire Metsera, Defeating Rival Bids from Novo Nordisk Pfizer acquires Metsera in a competitive $10 billion deal, boosting its position in the obesity drug market.

Pfizer Clinches $10 Billion Deal to Acquire Metsera, Defeating Rival Bids from Novo Nordisk

#pfizer #metsera #obesitytreatment #pharmaceutical #acquisition

Pfizer paie des milliards pour Metsera et renforce sa position sur le marché de l’obésité Principaux renseignements Pfizer a remporté une enchère de plusieurs milliards de dollars pour l’acquisition de Metsera, un spécialiste du traitement de l’obésité. Cette acquisition renforcera la position de Pfizer sur le marché très concurrentiel des médicaments amaigrissants. Elle contribuera également à compenser la baisse des ventes de ses médicaments contre la COVID-19. Conflit L’accord valorise […]

Pfizer paie des milliards pour Metsera et renforce sa position sur le marché de l’obésité #Pfizer #Metsera #Obésité #Santé #Médicaments

Pfizer betaalt miljarden voor Metsera en versterkt positie in obesitasmarkt Key takeaways Pfizer is als winnaar uit de bus gekomen bij een bod van meerdere miljarden dollars voor de overname van Metsera, een specialist in de behandeling van obesitas. De overname zal de positie van Pfizer op de zeer concurrerende markt voor afslankmedicijnen versterken. Bovendien zal het de dalende verkoop van zijn COVID-19-medicijnen helpen compenseren. […]

Pfizer betaalt miljarden voor Metsera en versterkt positie in obesitasmarkt #Pfizer #Metsera #obesitas #afslankmedicijnen #gezondheid

Everyone's In a Foul Mood A few things came to a head over the week — not the least of which was the eventual consummation of a deal for biotech company Metsera by Pfizer after a series of bids from rival Novo Nordisk that got...

Yes, it's Monday. So...another edition of your fair newsletter is here, talking #Metsera, #Thanksgiving, #Walmart and #consumersentiment. Enjoy!

www.linkedin.com/pulse/everyo...

Pfizer and Novo Nordisk’s battle over Metsera Lawsuits fly in bidding war over developer of next generation weight loss drugs

Pfizer and Novo Nordisk’s battle over Metsera #Science #HealthandMedicine #Oncology #Pfizer #NovoNordisk #Metsera

Pfizer rachète Metsera pour 10 milliards de dollars et mise sur le marché des médicaments contre l’obésité Principaux renseignements Pfizer a racheté Metsera pour 10 milliards de dollars (8,6 milliards d’euros), une victoire importante dans la bataille qui l’oppose à son concurrent Novo Nordisk. Cet accord permet à Pfizer d’entrer sur le marché lucratif des médicaments contre l’obésité, même si les traitements de Metsera ne seront pas commercialisés avant longtemps. La bataille […]

Pfizer rachète Metsera pour 10 milliards de dollars et mise sur le marché des médicaments contre l’obésité #Pfizer #Metsera #Médicaments #Obésité #Santé

Pfizer koopt Metsera voor 10 miljard dollar en zet in op markt voor obesitasmedicijnen Key takeaways Pfizer heeft Metsera overgenomen voor 10 miljard dollar (8,6 miljard euro), een belangrijke overwinning in de strijd met concurrent Novo Nordisk. De deal stelt Pfizer in staat om de lucratieve markt voor medicijnen tegen zwaarlijvigheid te betreden, hoewel de behandelingen van Metsera nog lang niet op de markt zullen komen. De biedingsstrijd begon […]

Pfizer koopt Metsera voor 10 miljard dollar en zet in op markt voor obesitasmedicijnen #Pfizer #Metsera #overname #obesitasmedicijnen #gezondheid

🏆 Pfizer just beat Novo Nordisk in a $10B showdown for Metsera, one of the fiercest pharma battles since the race for COVID vaccines. The deal gives Pfizer a new shot at dominating the booming obesity drug market.

🔗 t.ly/zDK0p
#Pfizer #NovoNordisk #Metsera #PharmaDeals #ObesityDrugs

Pfizer and Metsera's Amended Merger Agreement: What It Means for Shareholders Pfizer's revised merger agreement with Metsera, valuing shares at $86.25, is poised to create significant value for shareholders. The Board's unanimous recommendation signals optimism for the deal's success.

Pfizer and Metsera's Amended Merger Agreement: What It Means for Shareholders #None #Merger #Pfizer #Metsera

The battle for obesity drug developer #Metsera rumbles on, with #Pfizer reported to have now matched #NovoNordisk's $10 billion offer as the US #financialregulator said questions need to be answered about the legality of Novo's bid.

pharmaphorum.com/news/pfizer-...

Metsera Responds Effectively to Recent Litigation Ruling by Delaware Court Metsera, Inc. confidently addresses a Delaware Court ruling related to litigation by Pfizer, asserting their commitment to shareholder interests.

Metsera Responds Effectively to Recent Litigation Ruling by Delaware Court #Litigation #Pfizer #Metsera

FTC raises concern about Novo Nordisk attempt to acquire obesity startup Metsera The FTC has raised concerns about Novo Nordisk’s attempt to outbid Pfizer to acquire obesity startup Metsera.

FTC raises concern about Novo Nordisk attempt to acquire obesity startup Metsera.. statnews.com/pharmalot/20... #pharma #antitrust #FTC #obesity #weight #Pfizer #Metsera #NovoNordisk

Shareholder Alert: Actions Required Before Key Votes for CyberArk, TEGNA, Metsera, and Guess? Shareholder attention is drawn to critical upcoming votes regarding CyberArk, TEGNA, Metsera, and Guess?. Key actions are urged for affected parties.

Shareholder Alert: Actions Required Before Key Votes for CyberArk, TEGNA, Metsera, and Guess? #United_States #New_York #CyberArk #TEGNA #Metsera

Bidding war breaks out as Novo raises Metsera bid to $10bn Metsera has now received new takeover bids from both Pfizer and Novo Nordisk, and has plumped for a sweetened $10bn offer from the latter.

Obesity drug developer #Metsera has now received updated #takeover #offers from both #Pfizer and #NovoNordisk, and has come down in favour of a sweetened $10 billion bid from the latter.

pharmaphorum.com/news/bidding...

Novo Nordisk Outbids Pfizer in Acquisition Proposal for Metsera Metsera's board has declared Novo Nordisk's latest acquisition proposal superior, valuing the company at $10 billion, surpassing Pfizer's offer.

Novo Nordisk Outbids Pfizer in Acquisition Proposal for Metsera #United_States #New_York #Novo_Nordisk #Pfizer #Metsera

#Pfizer is leaving no stone unturned in its efforts to prevent #NovoNordisk from stealing off with #Metsera, the weight-loss therapy developer it is hoping to acquire in a deal worth up to $7.3 billion.

pharmaphorum.com/news/pfizer-...

Pfizer ramps up the fight! Files 2nd lawsuit vs. Novo Nordisk & Metsera, claiming their $9B bid is anticompetitive & violates antitrust laws—aiming to "kill" competition in GLP-1 drugs for obesity/diabetes. Drama in pharma world! #Pfizer #NovoNordisk #Metsera

Buying Tylenol for Headaches This may be the first time in history where someone bought Tylenol to give themselves a headache. But Kimberly Clark might have done it with a $40 billion deal to buy Kenvue, the Tylenol maker that ha...

It's Monday, which means another Business of America has landed! #Tylenol #AI #Metsera #OpenAI #Nvidia and anything else on my mind. Huzzah. Happy November.

www.linkedin.com/pulse/buying...

Metsera Responds Firmly to Litigation Filed by Pfizer Over Acquisition Attempts In light of Pfizer's recent litigation against Metsera, the company's board reaffirms its commitment to shareholders, rejecting Pfizer's tactics in the acquisition bid.

Metsera Responds Firmly to Litigation Filed by Pfizer Over Acquisition Attempts #USA #New_York #Litigation #Pfizer #Metsera

Pfizer sues to block Novo Nordisk's Metsera takeover bid Pfizer has filed a lawsuit to block a rival, higher bid for obesity therapy developer Metsera from Novo Nordisk, claiming it is anti-competitive.

#Pfizer has filed a #lawsuit against #NovoNordisk and #Metsera in an attempt to force through its #takeover of the weight-loss drug developer and prevent Novo Nordisk from taking its rival bid forward.

pharmaphorum.com/news/pfizer-...

Metsera Responds to Ongoing Litigation from Pfizer with Strong Denial Metsera, Inc. has publicly addressed the legal action initiated by Pfizer against the company, asserting disagreement with the claims in the lawsuit.

Metsera Responds to Ongoing Litigation from Pfizer with Strong Denial #USA #New_York #Acquisition #Pfizer #Metsera

Pharmalittle: We're reading about a bidding war for Metsera, HHS plans for speeding biosimilars, and more A bidding war between Novo Nordisk and Pfizer has broken into the open for Metsera, which focuses on developing drugs to treat obesity

Pharmalot.. Pharmalittle.. Good Morning: We’re reading about a bidding war for Metsera, HHS plans for speeding biosimilars, and more news.. statnews.com/pharmalot/20... #pharma #obesity #biologics #biosimilars #autism #Tylenol #Pfizer #NovoNordisk #Metsera #Merck #Kenvue

Novo tries to push Pfizer aside with $9bn bid for Metsera Novo Nordisk has launched an audacious bid to elope with weight-loss therapy developer Metsera, before it can go ahead with a marriage to Pfizer.

#NovoNordisk has launched an audacious bid to elope with #weightlosstherapy developer #Metsera, before it can go ahead with a marriage to #Pfizer.

Metsera's Board Declares Novo Nordisk Proposal 'Superior' Over Pfizer's Offer Metsera declares an unsolicited proposal from Novo Nordisk as superior to Pfizer's offer, valuing the shares significantly higher, raising key negotiations.

Metsera's Board Declares Novo Nordisk Proposal 'Superior' Over Pfizer's Offer #United_States #New_York #Novo_Nordisk #Pfizer #Metsera

Halper Sadeh LLC Launches Investigations into FSFG, MTSR, VRNT, MRUS for Shareholder Rights Halper Sadeh LLC is probing several companies for possible breaches of federal securities laws, focusing on helping shareholders secure their rights amid upcoming sales.

Halper Sadeh LLC Launches Investigations into FSFG, MTSR, VRNT, MRUS for Shareholder Rights #United_States #New_York #Verint #Metsera #First_Savings

Halper Sadeh LLC Investigates Various Corporations for Shareholder Rights Violations Halper Sadeh LLC is investigating Union Pacific, Metsera, and Steelcase for potential violations of federal securities laws impacting shareholders, aiming for their rights and benefits.

Halper Sadeh LLC Investigates Various Corporations for Shareholder Rights Violations #United_States #New_York #Halper_Sadeh #Union_Pacific #Metsera

M&A Class Action Firm Investigates Metsera's Sale to Pfizer: Shareholders Seek Fair Treatment The M&A Class Action Firm is investigating the sale of Metsera, Inc. to Pfizer Inc., ensuring shareholders receive a fair compensation under the new terms.

M&A Class Action Firm Investigates Metsera's Sale to Pfizer: Shareholders Seek Fair Treatment #United_States #New_York #Class_Action #Pfizer #Metsera

Pfizer makes a $4.9 billion move into the obesity drug market with Metsera acquisition Five months after discontinuing the development of its own obesity treatment, Pfizer has announced a nearly $5 billion acquisition of the development-stage drugmaker Metsera. The deal signals a major strategic push by the pharmaceutical giant into the rapidly growing and highly lucrative market for weight-loss drugs, which is currently dominated by Novo Nordisk’s Wegovy and […]